| Bioactivity | (S)-Mirtazapine-d3 is a deuterium labeled (S)-Mirtazapine. (S)-Mirtazapine is a S(+)-enantiomer of Mirtazapine with pronociceptive properties in an animal model of acute thermal nociception.(S)-Mirtazapine is a stereoselective 5-HT2 receptor antagonist. (S)-Mirtazapine is metabolized by CYP2D6 and CYP1A2[1]. | ||||||||||||
| Target | 5-HT2 receptor | ||||||||||||
| Name | (S)-Mirtazapine-d3 | ||||||||||||
| Formula | C17H16D3N3 | ||||||||||||
| Molar Mass | 268.37 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Muth-Selbach U, et al. Racemic intrathecal mirtazapine but not its enantiomers acts anti-neuropathic after chronic constriction injury in rats. Brain Res Bull. 2009 Apr 6;79(1):63-8. |